{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:02:08Z","timestamp":1784620928001,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX003025, IK6-BX006479"],"award-info":[{"award-number":["I01BX003025, IK6-BX006479"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31-DK130603"],"award-info":[{"award-number":["F31-DK130603"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) leads to significant bone loss and high risk of fractures. Fractures are even more prevalent in the aging population with CKD. Cortical bone is particularly impacted in CKD due to cortical thinning and the development of cortical porosity. The goal of this study was to assess the impact of romosozumab, a bone anabolic therapy, on cortical bone in young and aging mice with adenine-induced CKD. Male C57Bl6\/J mice, aged 16- and 66-weeks, were given 0.2% dietary adenine to induce CKD. Eight weeks after induction of CKD, a subset of young and aging adenine-CKD mice were given romosozumab (10\u00a0mg\/kg, 1x\/week for 4\u00a0weeks); the study also included age-matched healthy controls. At the study endpoint, all adenine-CKD mice had high blood urea nitrogen and parathyroid hormone compared to controls. Romosozumab-treated groups of both ages had higher trabecular bone volume due to increased trabecular thickness, indicating an anabolic effect of therapy. Romosozumab-treated young mice had higher midshaft femur cortical bone area and cortical thickness, but there were no differences in cortical porosity compared to untreated adenine. Aging mice had no differences in cortical thickness, but cortical pore number was lower with romosozumab treatment. Four-point-bending mechanical tests showed 20% higher ultimate force with romosozumab treatment in both ages, statistically different from untreated adenine in the young cohort. These data demonstrate positive cortical bone effects from four weeks of romosozumab treatment in both young and aging mice with established CKD.<\/jats:p>","DOI":"10.1007\/s00223-026-01577-9","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:06:27Z","timestamp":1784617587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Four weeks of romosozumab treatment increases trabecular bone volume and differentially improves cortical bone in young and aging mice with chronic kidney disease"],"prefix":"10.1007","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-8082","authenticated-orcid":false,"given":"Corinne E.","family":"Metzger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison R.","family":"Kolhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Santamaria","family":"Vilchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha P.","family":"Tippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon Y.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec N.","family":"LaPlant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia N.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"1577_CR1","unstructured":"Centers for Disease Control (2023) Chronic kidney disease in the United States, 2023"},{"key":"1577_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"CP Kovesdy 2022 Epidemiology of chronic kidney disease: an update 2022 Kidney Int Suppl 12 7 11 https:\/\/doi.org\/10.1016\/j.kisu.2021.11.003","journal-title":"Kidney Int Suppl"},{"key":"1577_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","volume":"58","author":"AM Alem","year":"2000","unstructured":"AM Alem DJ Sherrard DL Gillen 2000 Increased risk of hip fracture among patients with end-stage renal disease Kidney Int 58 396 399 https:\/\/doi.org\/10.1046\/j.1523-1755.2000.00178.x","journal-title":"Kidney Int"},{"key":"1577_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","volume":"25","author":"M Maravic","year":"2014","unstructured":"M Maravic A Ostertag PU Torres M Cohen-Solal 2014 Incidence and risk factors for hip fractures in dialysis patients Osteoporos Int 25 159 165 https:\/\/doi.org\/10.1007\/s00198-013-2435-1","journal-title":"Osteoporos Int"},{"key":"1577_CR5","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.kint.2017.07.021","volume":"92","author":"A Pimentel","year":"2017","unstructured":"A Pimentel P Ure\u00f1a-Torres MC Zillikens 2017 Fractures in patients with CKD\u2014diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation Kidney Int 92 1343 1355 https:\/\/doi.org\/10.1016\/j.kint.2017.07.021","journal-title":"Kidney Int"},{"key":"1577_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0121705","volume":"10","author":"CH Kuo","year":"2015","unstructured":"CH Kuo TC Hsieh CH Wang 2015 Increased risks of mortality and atherosclerotic complications in incident hemodialysis patients subsequently with bone fractures: a nationwide case-matched cohort study PLoS ONE 10 1 13 https:\/\/doi.org\/10.1371\/journal.pone.0121705","journal-title":"PLoS ONE"},{"key":"1577_CR7","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/ndt\/gfz142","volume":"35","author":"B Runesson","year":"2020","unstructured":"B Runesson M Trevisan K Iseri 2020 Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine measurement project Nephrol Dial Transplant 35 1908 1915 https:\/\/doi.org\/10.1093\/ndt\/gfz142","journal-title":"Nephrol Dial Transplant"},{"key":"1577_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/ki.2013.279","volume":"85","author":"F Tentori","year":"2014","unstructured":"F Tentori K McCullough RD Kilpatrick 2014 High rates of death and hospitalization follow bone fracture among hemodialysis patients Kidney Int 85 166 173 https:\/\/doi.org\/10.1038\/ki.2013.279","journal-title":"Kidney Int"},{"key":"1577_CR9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/ki.2013.547","volume":"86","author":"KL Naylor","year":"2014","unstructured":"KL Naylor E McArthur WD Leslie 2014 The three-year incidence of fracture in chronic kidney disease Kidney Int 86 810 818 https:\/\/doi.org\/10.1038\/ki.2013.547","journal-title":"Kidney Int"},{"key":"1577_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","volume":"70","author":"M Jadoul","year":"2006","unstructured":"M Jadoul JM Albert T Akiba 2006 Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study Kidney Int 70 1358 1366 https:\/\/doi.org\/10.1038\/sj.ki.5001754","journal-title":"Kidney Int"},{"key":"1577_CR11","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1916","volume":"28","author":"TL Nickolas","year":"2013","unstructured":"TL Nickolas EM Stein E Dworakowski 2013 Rapid cortical bone loss in patients with chronic kidney disease J Bone Miner Res 28 1811 1820 https:\/\/doi.org\/10.1002\/jbmr.1916","journal-title":"J Bone Miner Res"},{"key":"1577_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-019-00642-w","author":"CE Metzger","year":"2019","unstructured":"CE Metzger EA Swallow MR Allen 2019 Elevations in cortical porosity occur prior to significant rise in serum parathyroid hormone in young female mice with adenine\u2014induced CKD Calcif Tissue Int https:\/\/doi.org\/10.1007\/s00223-019-00642-w","journal-title":"Calcif Tissue Int"},{"key":"1577_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0250438","volume":"16","author":"CE Metzger","year":"2021","unstructured":"CE Metzger EA Swallow AJ Stacy MR Allen 2021 Adenine-induced chronic kidney disease induces a similar skeletal phenotype in male and female C57BL\/6 mice with more severe deficits in cortical bone properties of male mice PLoS ONE 16 1 13 https:\/\/doi.org\/10.1371\/journal.pone.0250438","journal-title":"PLoS ONE"},{"key":"1577_CR14","doi-asserted-by":"publisher","first-page":"101612","DOI":"10.1016\/j.bonr.2022.101612","volume":"17","author":"CE Metzger","year":"2022","unstructured":"CE Metzger CL Newman SP Tippen 2022 Cortical porosity occurs at varying degrees throughout the skeleton in rats with chronic kidney disease Bone Rep 17 101612 https:\/\/doi.org\/10.1016\/j.bonr.2022.101612","journal-title":"Bone Rep"},{"key":"1577_CR15","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/nejmoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"F Cosman DB Crittenden JD Adachi 2016 Romosozumab treatment in postmenopausal women with osteoporosis N Engl J Med 375 1532 1543 https:\/\/doi.org\/10.1056\/nejmoa1607948","journal-title":"N Engl J Med"},{"key":"1577_CR16","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/nejmoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"KG Saag J Petersen ML Brandi 2017 Romosozumab or alendronate for fracture prevention in women with osteoporosis N Engl J Med 377 1417 1427 https:\/\/doi.org\/10.1056\/nejmoa1708322","journal-title":"N Engl J Med"},{"key":"1577_CR17","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1210\/jc.2017-02163","volume":"103","author":"EM Lewiecki","year":"2018","unstructured":"EM Lewiecki T Blicharski S Goemaere 2018 A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis J Clin Endocrinol Metab 103 3183 3193 https:\/\/doi.org\/10.1210\/jc.2017-02163","journal-title":"J Clin Endocrinol Metab"},{"key":"1577_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1002\/jbmr.3735","volume":"34","author":"P Chavassieux","year":"2019","unstructured":"P Chavassieux R Chapurlat N Portero-Muzy 2019 Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment J Bone Miner Res 34 1597 1608 https:\/\/doi.org\/10.1002\/jbmr.3735","journal-title":"J Bone Miner Res"},{"key":"1577_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bone.2016.10.019","volume":"96","author":"MS Ominsky","year":"2017","unstructured":"MS Ominsky RW Boyce X Li HZ Ke 2017 Effects of sclerostin antibodies in animal models of osteoporosis Bone 96 63 75 https:\/\/doi.org\/10.1016\/j.bone.2016.10.019","journal-title":"Bone"},{"key":"1577_CR20","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jbmr.4563","volume":"37","author":"PD Miller","year":"2022","unstructured":"PD Miller JD Adachi BH Albergaria 2022 Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease J Bone Miner Res 37 1437 1445 https:\/\/doi.org\/10.1002\/jbmr.4563","journal-title":"J Bone Miner Res"},{"key":"1577_CR21","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00774-022-01332-8","volume":"40","author":"A Miyauchi","year":"2022","unstructured":"A Miyauchi E Hamaya K Nishi 2022 Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease J Bone Miner Metab 40 677 687","journal-title":"J Bone Miner Metab"},{"key":"1577_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00774-025-01651-6","volume":"43","author":"M Sato","year":"2025","unstructured":"M Sato 2025 Treatment with romosozumab in patients with osteoporosis on maintenance hemodialysis J Bone Miner Metab 43 611 614","journal-title":"J Bone Miner Metab"},{"key":"1577_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00223-022-01031-6","volume":"112","author":"T Saito","year":"2023","unstructured":"T Saito M Mizobuchi T Kato 2023 One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study Calcif Tissue Int 112 34 44 https:\/\/doi.org\/10.1007\/s00223-022-01031-6","journal-title":"Calcif Tissue Int"},{"key":"1577_CR24","doi-asserted-by":"publisher","first-page":"ziaf049","DOI":"10.1093\/jbmrpl\/ziaf049","volume":"9","author":"A Tominaga","year":"2025","unstructured":"A Tominaga K Wada Y Kato K Okazaki 2025 Romosozumab for managing severe osteoporosis in patients undergoing kidney transplantation: a retrospective case series JBMR Plus 9 ziaf049 https:\/\/doi.org\/10.1093\/jbmrpl\/ziaf049","journal-title":"JBMR Plus"},{"key":"1577_CR25","doi-asserted-by":"publisher","first-page":"e0324628","DOI":"10.1371\/journal.pone.0324628","volume":"20","author":"CE Metzger","year":"2025","unstructured":"CE Metzger LY Tak S Scholz MR Allen 2025 Prolonged secondary hyperparathyroidism in adenine-induced CKD leads to skeletal changes consistent with skeletal hyporesponsiveness to PTH PLoS ONE 20 e0324628 https:\/\/doi.org\/10.1371\/journal.pone.0324628","journal-title":"PLoS ONE"},{"key":"1577_CR26","doi-asserted-by":"publisher","first-page":"116228","DOI":"10.1016\/j.bone.2021.116228","volume":"154","author":"SP Tippen","year":"2022","unstructured":"SP Tippen CE Metzger EA Swallow 2022 The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype Bone 154 116228 https:\/\/doi.org\/10.1016\/j.bone.2021.116228","journal-title":"Bone"},{"key":"1577_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10473","author":"R Kohler","year":"2021","unstructured":"R Kohler CA Tastad AJ Stacy 2021 The effect of single versus group \u03bcCT on the detection of trabecular and cortical disease phenotypes in mouse bones JBMR Plus https:\/\/doi.org\/10.1002\/jbm4.10473","journal-title":"JBMR Plus"},{"key":"1577_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jbmr.4235","volume":"36","author":"DE Robinson","year":"2021","unstructured":"DE Robinson MS Ali N Pallares 2021 Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis J Bone Miner Res 36 820 832 https:\/\/doi.org\/10.1002\/jbmr.4235","journal-title":"J Bone Miner Res"},{"key":"1577_CR29","doi-asserted-by":"publisher","first-page":"101174","DOI":"10.1016\/j.bonr.2022.101174","volume":"16","author":"EA Swallow","year":"2022","unstructured":"EA Swallow CE Metzger NX Chen 2022 Cortical porosity is elevated after a single dose of zoledronate in two rodent models of chronic kidney disease Bone Rep 16 101174 https:\/\/doi.org\/10.1016\/j.bonr.2022.101174","journal-title":"Bone Rep"},{"key":"1577_CR30","doi-asserted-by":"publisher","first-page":"115632","DOI":"10.1016\/j.bone.2020.115632","volume":"143","author":"CE Metzger","year":"2020","unstructured":"CE Metzger EA Swallow AJ Stacy 2020 Reversing cortical porosity: cortical pore infilling in preclinical models of chronic kidney disease Bone 143 115632 https:\/\/doi.org\/10.1016\/j.bone.2020.115632","journal-title":"Bone"},{"key":"1577_CR31","doi-asserted-by":"publisher","first-page":"116340","DOI":"10.1016\/j.bone.2022.116340","volume":"157","author":"EA Swallow","year":"2022","unstructured":"EA Swallow CE Metzger CL Newman 2022 Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease Bone 157 116340 https:\/\/doi.org\/10.1016\/j.bone.2022.116340","journal-title":"Bone"},{"key":"1577_CR32","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1681\/ASN.2014040414","volume":"26","author":"SM Moe","year":"2015","unstructured":"SM Moe S Abdalla GM Chertow 2015 Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial J Am Soc Nephrol 26 1466 1475 https:\/\/doi.org\/10.1681\/ASN.2014040414","journal-title":"J Am Soc Nephrol"},{"key":"1577_CR33","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","volume":"39","author":"M Sato","year":"2021","unstructured":"M Sato M Inaba S Yamada 2021 Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study J Bone Miner Metab 39 1082 1090 https:\/\/doi.org\/10.1007\/s00774-021-01253-y","journal-title":"J Bone Miner Metab"},{"key":"1577_CR34","doi-asserted-by":"publisher","first-page":"101774","DOI":"10.1016\/j.bonr.2024.101774","volume":"21","author":"R Kohler","year":"2024","unstructured":"R Kohler DM Segvich O Reul 2024 Romosozumab rescues impaired bone mass and strength in a murine model of diabetic kidney disease Bone Rep 21 101774 https:\/\/doi.org\/10.1016\/j.bonr.2024.101774","journal-title":"Bone Rep"},{"key":"1577_CR35","doi-asserted-by":"publisher","first-page":"117415","DOI":"10.1016\/j.bone.2025.117415","volume":"194","author":"R Kohler","year":"2025","unstructured":"R Kohler DM Segvich O Reul 2025 Combined Romosozumab and Raloxifene treatment targets impaired bone quality in a male murine model of diabetic kidney disease Bone 194 117415 https:\/\/doi.org\/10.1016\/j.bone.2025.117415","journal-title":"Bone"},{"key":"1577_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/jbmr.2372","volume":"30","author":"SM Moe","year":"2015","unstructured":"SM Moe NX Chen CL Newman 2015 Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy J Bone Miner Res 30 539 549 https:\/\/doi.org\/10.1002\/jbmr.2372","journal-title":"J Bone Miner Res"},{"key":"1577_CR37","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/en.2004-0770","volume":"146","author":"E Knopp","year":"2005","unstructured":"E Knopp N Troiano M Bouxsein 2005 The effect of aging on the skeletal response to intermittent treatment with parathyroid hormone Endocrinology 146 1983 1990 https:\/\/doi.org\/10.1210\/en.2004-0770","journal-title":"Endocrinology"},{"issue":"4","key":"1577_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/BF00301627","volume":"50","author":"CT Rubin","year":"1992","unstructured":"CT Rubin SD Bain KJ Mcleod 1992 Calcified tissue international laboratory investigations suppression of the osteogenic response in the aging skeleton Calcif Tissue Int 50 4 306 313","journal-title":"Calcif Tissue Int"},{"key":"1577_CR39","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/jbmr.5650101016","volume":"10","author":"CH Turner","year":"1995","unstructured":"CH Turner Y Takano I Owan 1995 Aging changes mechanical loading thresholds for bone formation in rats J Bone Miner Res 10 1544 1549 https:\/\/doi.org\/10.1002\/jbmr.5650101016","journal-title":"J Bone Miner Res"},{"key":"1577_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bone.2014.05.006","volume":"65","author":"N Holguin","year":"2014","unstructured":"N Holguin MD Brodt ME Sanchez MJ Silva 2014 Aging diminishes lamellar and woven bone formation induced by tibial compression in adult C57BL\/6 Bone 65 83 91 https:\/\/doi.org\/10.1016\/j.bone.2014.05.006","journal-title":"Bone"},{"key":"1577_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jbmrpl\/ziae004","volume":"8","author":"CE Metzger","year":"2024","unstructured":"CE Metzger M Kittaka AN LaPlant 2024 Inhibition of RANKL improves the skeletal phenotype of adenine-induced chronic kidney disease in mice JBMR Plus 8 1 13 https:\/\/doi.org\/10.1093\/jbmrpl\/ziae004","journal-title":"JBMR Plus"},{"key":"1577_CR42","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/jcph.2050","volume":"62","author":"CP Hsu","year":"2022","unstructured":"CP Hsu J Maddox G Block 2022 Influence of renal function on pharmacokinetics, pharmacodynamics, and safety of a single dose of romosozumab J Clin Pharmacol 62 1132 1141 https:\/\/doi.org\/10.1002\/jcph.2050","journal-title":"J Clin Pharmacol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-026-01577-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-026-01577-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T07:06:29Z","timestamp":1784617589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-026-01577-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1577"],"URL":"https:\/\/doi.org\/10.1007\/s00223-026-01577-9","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"116"}}